Lupus clinical trial eligibility in a real-world setting: results from the British Isles Lupus Assessment Group-Biologics Register (BILAG-BR)

OBJECTIVE: To quantify how well phase III randomised clinical trials in both SLE and lupus nephritis (LN) represents a real-world SLE cohort. METHODS: Literature reviews were performed of major published phase III SLE (n=12) and LN (n=6) clinical trials (ClinicalTrials.gov). Inclusion and exclusion...

Descripción completa

Detalles Bibliográficos
Autores principales: Dyball, Sarah, Collinson, Sophie, Sutton, Emily, McCarthy, Eoghan M, Bruce, Ian N, Parker, Ben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Clinical Trials and Drug Discovery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311338/
https://www.ncbi.nlm.nih.gov/pubmed/34301852
http://dx.doi.org/10.1136/lupus-2021-000513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311338/
https://www.ncbi.nlm.nih.gov/pubmed/34301852
http://dx.doi.org/10.1136/lupus-2021-000513

Ejemplares similares